FORGE BIOLOGICS HOLDINGS, LLC

Profile

Company Names

FORGE BIOLOGICS HOLDINGS, LLC

Addresses

3900 GANTZ ROAD, GROVE CITY, OH 43123

Phone Numbers

2162875408

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$159,999,889.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-04-28 
$119,999,889.00 
$119,999,889.00 
$0.00 
Equity 
1
2020-07-20 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MOLLY 
 
BONAKDARPOUR 
DIRECTOR
CIRRUSMD INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  SONDERMIND INC.   |  BATTLEFACE, INC.   |  WOOP GROUP, INC.   |  CLARENCE HEALTH INC.   |  CONDUIT HEALTH INC.
FREDERICK 
 
CALLORI 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  CEREVASC, INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  JUNO DIAGNOSTICS, INC.   |  POLYCORE THERAPEUTICS, INC.
CHRIS 
 
GARABEDIAN 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  VYOME THERAPEUTICS INC.   |  CEREVASC, INC.   |  NEPHRODI THERAPEUTICS, INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  SHIFA BIOMEDICAL CORP   |  JUNO DIAGNOSTICS, INC.   |  TELLUS THERAPEUTICS, INC.   |  STREAM BIOMEDICAL, INC.   |  POLYCORE THERAPEUTICS, INC.   |  VIVOSENSE, INC.   |  ASCLEPIX THERAPEUTICS, INC.   |  MAREA THERAPEUTICS, INC.   |  ZUCARA THERAPEUTICS INC.
CHRIS 
J. 
GARABEDIAN 
DIRECTOR
FORGE BIOLOGICS HOLDINGS, LLC
MATTHEW 
 
HAMMOND 
DIRECTOR
NAUTILUS MINERALS INC   |  REALM THERAPEUTICS PLC   |  INDEFINITE INTEGRAL INC   |  CEREBRAL THERAPEUTICS, INC.   |  DTX PHARMA, INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  JNANA THERAPEUTICS INC.   |  PATHIFY HOLDINGS INC.
MOLLY 
J. 
MCCARTIN 
DIRECTOR
FORGE BIOLOGICS HOLDINGS, LLC
TIMOTHY 
J. 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
DORMIR, INC.   |  WADDELL + REED SMALL CO GROWTH FUND, LLC   |  FORGE BIOLOGICS HOLDINGS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-05-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-28 
2020-08-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#